Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Rob Pieters

Pediatric oncologist
--
Phone 088 97 28 589
  • Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL

    • mei 2024
    • Inge M, van der Sluis, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups

    • sep. 2023
    • Rob, Pieters, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Implementation of paediatric precision oncology into clinical practice

    • nov. 2022
    • Karin P.S., Langenberg, et al
    • European Journal of Cancer
  • Depletion of d- and l-asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy

    • nov. 2022
    • Leiah J., Brigitha, et al
    • Pediatric Blood and Cancer
  • MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus

    • jul. 2022
    • Kirsten, Canté-Barrett, et al
    • JCI Insight
View all publications